Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Collegium Pharmaceutical, Inc. (COLL)

21.87   -0.53 (-2.37%) 12-07 16:00
Open: 22.39 Pre. Close: 22.4
High: 22.745 Low: 21.87
Volume: 132,260 Market Cap: 734(M)

Technical analysis

as of: 2022-12-07 4:21:16 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 27.17     One year: 31.74
Support: Support1: 19.3    Support2: 16.85
Resistance: Resistance1: 23.27    Resistance2: 27.17
Pivot: 21.89
Moving Average: MA(5): 22.57     MA(20): 21.42
MA(100): 18.39     MA(250): 18.11
MACD: MACD(12,26): 0.9     Signal(9): 1
Stochastic oscillator: %K(14,3): 68.2     %D(3): 81.5
RSI: RSI(14): 58.3
52-week: High: 23.27  Low: 14.03
Average Vol(K): 3-Month: 225 (K)  10-Days: 179 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ COLL ] has closed above bottom band by 48.9%. Bollinger Bands are 14.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 22.79 - 22.93 22.93 - 23.03
Low: 21.55 - 21.73 21.73 - 21.86
Close: 21.64 - 21.9 21.9 - 22.09

Company Description

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Headline News

Tue, 06 Dec 2022
Coll. of Charleston 67, Presbyterian 62 | Wire | - Chronicle-Tribune

Tue, 06 Dec 2022
Coll. of Charleston 67, Presbyterian 62 | Agate | -

Tue, 06 Dec 2022
AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline -

Tue, 06 Dec 2022
Dolese Bros. Co. donates mixer truck to fire department - The Oklahoma 100

Mon, 05 Dec 2022
Insider Selling: Collegium Pharmaceutical, Inc. (NASDAQ:COLL) CEO Sells 76653 Shares of Stock - MarketBeat

Wed, 30 Nov 2022
'A Very DC Book': Chat With Author Susan Coll About 'Bookish People' - NBC4 Washington

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 34 (M)
Shares Float 30 (M)
% Held by Insiders 1.2 (%)
% Held by Institutions 111.1 (%)
Shares Short 3,840 (K)
Shares Short P.Month 3,800 (K)

Stock Financials

EPS 1.11
EPS Est Next Qtl -0.74
EPS Est This Year -3
EPS Est Next Year -1.88
Book Value (p.s.) 5.84
Profit Margin (%) -11.9
Operating Margin (%) 13.8
Return on Assets (ttm) 3.2
Return on Equity (ttm) -19.2
Qtrly Rev. Growth 61
Gross Profit (p.s.) 6.48
Sales Per Share 10.77
EBITDA (p.s.) 4.85
Qtrly Earnings Growth -95.5
Operating Cash Flow 94 (M)
Levered Free Cash Flow 93 (M)

Stock Valuations

PE Ratio 19.7
PEG Ratio -58.3
Price to Book value 3.74
Price to Sales 2.02
Price to Cash Flow 7.8

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.